Animal models of acute lung injury

被引:1404
作者
Matute-Bello, Gustavo [1 ,2 ]
Frevert, Charles W. [1 ,3 ]
Martin, Thomas R. [1 ]
机构
[1] Univ Washington, Sch Med, Med Res Serv, Seattle, WA USA
[2] Univ Washington, Sch Med, Dept Med, Div Pulm & Crit Care Med,Ctr Lung Biol, Seattle, WA 98195 USA
[3] Univ Washington, Sch Med, Dept Comparat Med, Seattle, WA 98195 USA
关键词
acute respiratory distress syndrome; human lung injury;
D O I
10.1152/ajplung.00010.2008
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Acute lung injury in humans is characterized histopathologically by neutrophilic alveolitis, injury of the alveolar epithelium and endothelium, hyaline membrane formation, and microvascular thrombi. Different animal models of experimental lung injury have been used to investigate mechanisms of lung injury. Most are based on reproducing in animals known risk factors for ARDS, such as sepsis, lipid embolism secondary to bone fracture, acid aspiration, ischemia-reperfusion of pulmonary or distal vascular beds, and other clinical risks. However, none of these models fully reproduces the features of human lung injury. The goal of this review is to summarize the strengths and weaknesses of existing models of lung injury. We review the specific features of human ARDS that should be modeled in experimental lung injury and then discuss specific characteristics of animal species that may affect the pulmonary host response to noxious stimuli. We emphasize those models of lung injury that are based on reproducing risk factors for human ARDS in animals and discuss the advantages and disadvantages of each model and the extent to which each model reproduces human ARDS. The present review will help guide investigators in the design and interpretation of animal studies of acute lung injury.
引用
收藏
页码:L379 / L399
页数:21
相关论文
共 50 条
[41]   Endothelial pathomechanisms in acute lung injury [J].
Maniatis, Nikolaos A. ;
Kotanidou, Anastasia ;
Catravas, John D. ;
Orfanos, Stylianos E. .
VASCULAR PHARMACOLOGY, 2008, 49 (4-6) :119-133
[42]   Pulmonary surfactant in acute lung injury [J].
Cane, RD ;
Neymour, R .
CRITICAL CARE MEDICINE, 1999, 27 (01) :12-13
[43]   Translational medicine for acute lung injury [J].
Jianguo Zhang ;
Yumeng Guo ;
Michael Mak ;
Zhimin Tao .
Journal of Translational Medicine, 22
[44]   Emerging drugs for acute lung injury [J].
Impellizzeri, Daniela ;
Bruschetta, Giuseppe ;
Esposito, Emanuela ;
Cuzzocrea, Salvatore .
EXPERT OPINION ON EMERGING DRUGS, 2015, 20 (01) :75-89
[45]   Adoptive transfer of acute lung injury [J].
Moxley, MA ;
Baird, TL ;
Corbett, JA .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 279 (05) :L985-L993
[46]   Progenitor cells in acute lung injury [J].
Burnham, E. ;
Moss, M. .
MINERVA ANESTESIOLOGICA, 2006, 72 (06) :369-374
[47]   Coagulation Disorders in Acute Lung Injury [J].
Adda, Melanie ;
Ferrer, Ricard ;
Puig, Ferranda ;
Crespo, Javier ;
Artigas, Antoni .
CURRENT RESPIRATORY MEDICINE REVIEWS, 2009, 5 (03) :149-159
[48]   Acute lung injury and the acute respiratory distress syndrome [J].
Luce, JM .
CRITICAL CARE MEDICINE, 1998, 26 (02) :369-376
[49]   New approaches to acute lung injury [J].
Bigatello, LM ;
Zapol, WM .
BRITISH JOURNAL OF ANAESTHESIA, 1996, 77 (01) :99-109
[50]   Coagulation and inflammation in acute lung injury [J].
Welty-Wolf, KE ;
Carraway, MS ;
Ortel, TL ;
Piantadosi, CA .
THROMBOSIS AND HAEMOSTASIS, 2002, 88 (01) :17-25